Gener8 LLC, a portfolio company of Sverica Capital Management LP, has acquired the RND Group, a provider of software development with a focus on medical device and life science products.
The deal enables Gener8 to add full lifecycle software development capabilities for could services, verification and validation, quality system compliance EHR integration and more. RND enables Gener8 to extend its turnkey instrument and consumable services to related software.
“RND is a world-class medical software development operation with a blue-chip customer base and a unique set of capabilities,” said Jerry Jurkiewicz, Gener8 CEO. “We have already partnered on several programs, and the value proposition of the combination has strongly resonated with customers.”